Since YouGraduatedExplore Timeline
DisprovedChanged2023

There is no pill for postpartum depression

The old claim turned out to be wrong and was rejected by evidence.

TaughtPostpartum depression is treated with the same general antidepressants used for everything else, which take weeks to work. There is no medication designed specifically for it, and the one dedicated drug that existed required a 60-hour IV infusion in a hospital.

NowOn 4 August 2023 the FDA approved Zurzuvae (zuranolone), the first oral medication developed specifically for postpartum depression, a once-daily pill taken for 14 days that can improve symptoms within days rather than weeks.

What actually happened

The dedicated predecessor, brexanolone, worked but was impractical: a multi-day intravenous drip under monitoring, out of reach for most new parents. Zuranolone delivers a related approach as a two-week course of pills taken at home, targeting the same GABA-A receptor system rather than the serotonin pathway of standard antidepressants.

The honest limits belong on the card: it is a short course, not a cure, some patients relapse, and the FDA declined the same drug for general major depression. But the specific claim (that there is no pill made for postpartum depression, only slow general antidepressants or a hospital infusion) no longer holds.

Newsletter

Get new weekly revisions

Join 3,821 readers

Sources

  1. FDA: FDA Approves First Oral Treatment for Postpartum Depressionfda.gov
  2. Biogen: FDA Approves ZURZUVAE (zuranolone), the First and Only Oral Treatment for Women with Postpartum Depressioninvestors.biogen.com

Who was taught this

Still standard through 2023, so anyone who finished school between 1950 and 2023 learned the earlier version.